María D. M.
- Country
- Spain
- Department
- Department of oncology
Research Overview
- Phase 1 Evaluation of BL-B01D1 Safety, Tolerability, and Efficacy in Metastatic or Unresectable Non-Small Cell Lung Cancer and Other Solid Tumors
- Evaluation of STX-721 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Specific Mutations
- Phase I/Ib Clinical Evaluation of PM54 in Patients with Advanced Solid Tumors
Data & Insights
Has run more than one trial at 96 of 217 partner sites.
Specializations
Lung Cancer Research
The investigator specializes in various forms of lung malignancies, with particular emphasis on non-small cell lung cancer and small cell lung cancer. Their research encompasses studies of novel targeted therapies and immunotherapy approaches.
- EGFR and HER2 mutations
- ROS1-positive tumors
- KRAS G12C mutations
Gastrointestinal Oncology
Focus on advancing treatments for digestive system cancers, including gastric cancer, pancreatic ductal adenocarcinoma, and colorectal cancer. The research includes evaluation of targeted therapies and immunological approaches.
- Gastroesophageal junction carcinoma
- Advanced pancreatic cancer
- Microsatellite instability tumors
Advanced Solid Tumors
Investigation of novel therapeutic approaches for various advanced solid malignancies, with particular attention to molecular targeting and immunotherapy combinations. Research includes studies of HER2-expressing cancers and tumors with specific genetic alterations.
- Genetic mutation-directed therapies
- Immunotherapy combinations
- Novel drug delivery systems
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.